136 related articles for article (PubMed ID: 3317753)
41. Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
Kremer JP; Jarrar D; Steckholzer U; Ertel W
Acta Haematol; 1996; 95(3-4):268-73. PubMed ID: 8677754
[TBL] [Abstract][Full Text] [Related]
42. Sepsis induces an early increased spontaneous release of hepatocellular stimulatory factor (interleukin-6) by Kupffer cells in both endotoxin tolerant and intolerant mice.
Ayala A; Perrin MM; Wang P; Chaudry IH
J Surg Res; 1992 Jun; 52(6):635-41. PubMed ID: 1528041
[TBL] [Abstract][Full Text] [Related]
43. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
Herbelin A; Machavoine F; Dy M
Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
[TBL] [Abstract][Full Text] [Related]
44. Possible role of tumor necrosis factor-alpha in erythropoietic suppression by endotoxin and granulocyte/macrophage colony-stimulating factor.
Udupa KB; Sharma BG
Am J Hematol; 1996 Jul; 52(3):178-83. PubMed ID: 8756083
[TBL] [Abstract][Full Text] [Related]
45. Endotoxin-induced tumor necrosis factor (TNF): selective triggering of TNF and interleukin-1 production by distinct glucosamine-derived lipids.
Lasfargues A; Chaby R
Cell Immunol; 1988 Aug; 115(1):165-78. PubMed ID: 3135943
[TBL] [Abstract][Full Text] [Related]
46. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor.
Neta R; Perlstein R; Vogel SN; Ledney GD; Abrams J
J Exp Med; 1992 Mar; 175(3):689-94. PubMed ID: 1311016
[TBL] [Abstract][Full Text] [Related]
47. Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha 1.
Vogel SN; Douches SD; Kaufman EN; Neta R
J Immunol; 1987 Apr; 138(7):2143-8. PubMed ID: 3494061
[TBL] [Abstract][Full Text] [Related]
48. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
[TBL] [Abstract][Full Text] [Related]
49. Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factor.
Broudy VC; Kaushansky K; Shoemaker SG; Aggarwal BB; Adamson JW
J Immunol; 1990 May; 144(10):3789-94. PubMed ID: 1692060
[TBL] [Abstract][Full Text] [Related]
50. Prolongation of skin allografts by recombinant tumor necrosis factor and interleukin-1.
Parenteau GL; Doherty GM; Peplinski GR; Tsung K; Norton JA
Ann Surg; 1995 May; 221(5):572-7; discussion 577-8. PubMed ID: 7748039
[TBL] [Abstract][Full Text] [Related]
51. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans.
Kuhns DB; Alvord WG; Gallin JI
J Infect Dis; 1995 Jan; 171(1):145-52. PubMed ID: 7528250
[TBL] [Abstract][Full Text] [Related]
52. Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans.
van Deventer SJ; Hart M; van der Poll T; Hack CE; Aarden LA
J Infect Dis; 1993 Feb; 167(2):461-54. PubMed ID: 8421182
[TBL] [Abstract][Full Text] [Related]
53. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells.
Sakaguchi S; Furusawa S; Wu J; Nagata K
Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386
[TBL] [Abstract][Full Text] [Related]
54. Inhibiting interleukin-1 and tumor necrosis factor-alpha does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo.
Emeis JJ; Hoekzema R; de Vos AF
Blood; 1995 Jan; 85(1):115-20. PubMed ID: 7803788
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 1 and tumor necrosis factor-alpha additively increase the levels of granulocyte-macrophage and granulocyte colony-stimulating factor (CSF) mRNA in human fibroblasts.
Seelentag W; Mermod JJ; Vassalli P
Eur J Immunol; 1989 Jan; 19(1):209-12. PubMed ID: 2465902
[TBL] [Abstract][Full Text] [Related]
56. [Cytokines and severe infections].
Offenstadt G; Guidet B; Staikowsky F
Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):820-31. PubMed ID: 8309725
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-3 enhances cytokine production by LPS-stimulated macrophages.
Cohen L; David B; Cavaillon JM
Immunol Lett; 1991 May; 28(2):121-6. PubMed ID: 1885210
[TBL] [Abstract][Full Text] [Related]
58. Protective effect of tumor necrosis factor-alpha against subsequent endotoxemia in mice is mediated, in part, by interleukin-10.
Murphey ED; Traber DL
Crit Care Med; 2001 Sep; 29(9):1761-6. PubMed ID: 11546981
[TBL] [Abstract][Full Text] [Related]
59. Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1 beta.
Herbein G; Doyle AG; Montaner LJ; Gordon S
Clin Exp Immunol; 1995 Nov; 102(2):430-7. PubMed ID: 7586702
[TBL] [Abstract][Full Text] [Related]
60. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
